Study: Virtual reality reduced pain scores by 24%

Oculus Rift
A new study shows virtual reality headsets could be an effective pain management tool.

Hospitals may soon be replacing pain medication with a virtual reality headset, following new evidence that the technology can help manage pain.

Researchers at Cedars-Sinai Medical Center in Los Angeles found virtual reality headsets could be a safe and effective alternative therapy for pain management, according to a study published in the Journal of Medical Internet Research Mental Health.

Comparing patients using a Samsung Gear Oculus VR headset versus a control group that had patients watch a nature video on a 14-inch television screen, researchers found patients using VR had a 24% drop in their pain scores, almost double those who were watching on a television.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

A recent study released this week showed virtual reality can be used to prepare surgical residents for their first days of trauma care, and others have said VR is “arguably the most exciting technology in medical education on the horizon today.”

Lead author of the study, Brennan Spiegel, M.D., has said VR is an untapped resource for pain management and envisions “prescribing” VR sessions to patients. But the study noted that more research is needed to understand the true impact.

Suggested Articles

Memorial Sloan Kettering Cancer Center has tapped former CVS Health and Aetna executive Claus Torp Jensen, Ph.D., as its first chief digital officer.

NYC Health + Hospitals plans to upgrade millions of imaging technologies across the health system as part of a $224 million deal with GE Healthcare.

A New Orleans-based genetic testing company will pay $42.6 million to resolve False Claims Act and kickback allegations.